Published in Lancet on January 18, 1992
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol (1993) 2.14
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (1997) 2.12
Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol (1995) 1.81
Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am J Pathol (2002) 1.62
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol (1996) 1.58
TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion. J Hematol Oncol (2015) 1.47
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol (1995) 1.27
Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. J Clin Invest (1996) 1.27
(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci U S A (1994) 1.24
Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer. Cancer Cell (2007) 1.17
Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc Natl Acad Sci U S A (1995) 1.13
Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach. Br J Cancer (1997) 1.12
Dmp1 and tumor suppression. Oncogene (2007) 1.10
Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res (2012) 1.05
Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis. Breast Cancer Res (2011) 0.97
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer. Oncogene (2012) 0.95
Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas. Am J Pathol (2002) 0.94
Common fragile site tumor suppressor genes and corresponding mouse models of cancer. J Biomed Biotechnol (2010) 0.93
Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development. Cancer Res (2010) 0.92
Role of DMP1 and its future in lung cancer diagnostics. Expert Rev Mol Diagn (2008) 0.91
Genetic prognostic index influences patient outcome for node-positive breast cancer. Surg Today (2006) 0.89
miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4. Mol Cells (2014) 0.87
Emerging roles of DMP1 in lung cancer. Cancer Res (2008) 0.86
The use of loss of constitutional heterozygosity data to ascertain the location of predisposing genes in cancer families. J Med Genet (1994) 0.86
Dmp1α inhibits HER2/neu-induced mammary tumorigenesis. PLoS One (2013) 0.84
Construction of a high-resolution physical map of the approximate 1-Mb region of human chromosome 7q31.1-q31.2 harboring a putative tumor suppressor gene. Neoplasia (1999) 0.83
Loss of heterozygosity, chromosome 7q, and breast cancer. Lancet (1992) 0.83
Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization. Am J Pathol (1997) 0.82
Signal transduction involving the dmp1 transcription factor and its alteration in human cancer. Clin Med Oncol (2008) 0.82
Loss of heterozygosity of the oestrogen receptor gene in breast cancer. Br J Cancer (1995) 0.81
Lack of Correlation Between Survival and Allele Loss on Chromosome 7q31-32 in Primary Breast Cancer. Pathol Oncol Res (1996) 0.79
Molecular genetics of cancer. BMJ (1992) 0.79
Loss of heterozygosity on chromosome 7q31 in breast cancer. Lancet (1993) 0.79
Molecular alterations associated with breast cancer mortality. PLoS One (2012) 0.79
Chromosomal localization of rat hepatocyte growth factor (Hgf) and HGF receptor (Met) and characterization of HGF receptor cDNA. Mamm Genome (1997) 0.77
Low Frequency Loss of Heterozygosity in the BRCA1 Region in Japanese Sporadic Breast Cancer. Breast Cancer (1996) 0.77
Aberrant expression of cyclin D1 in cancer. Sign Transduct Insights (2015) 0.76
Epstein-Barr virus growth-transformed cells are converted to malignancy following transfection of a 1.3-kb CATR1 antisense construct independent of a change in the level of c-myc expression followed by a 8;14 chromosomal translocation. Proc Natl Acad Sci U S A (1998) 0.75
Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas. Br J Cancer (2003) 0.75
From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform. Int J Mol Sci (2017) 0.75
Notch signaling is essential for vascular morphogenesis in mice. Genes Dev (2000) 6.88
Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res (1999) 4.74
Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci U S A (1975) 2.71
Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol (1989) 2.69
Detection of baboon type C viral sequences in various primate tissues by molecular hybridization. J Virol (1974) 2.69
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci U S A (1986) 2.66
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet (1998) 2.59
Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev (1992) 2.59
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst (1994) 2.58
Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer (1998) 2.52
Nucleic acid homology of murine type-C viral genes. J Virol (1974) 2.51
Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. J Virol (1987) 2.51
Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells. J Virol (1992) 2.29
Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol (2001) 2.29
Major pol gene progenitors in the evolution of oncoviruses. Science (1984) 2.28
Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science (1987) 2.17
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer (1998) 2.09
Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma. J Natl Cancer Inst (1989) 2.09
Two distinct endogenous type C viruses isolated from the asian rodent Mus cervicolor: conservation of virogene sequences in related rodent species. J Virol (1977) 1.98
Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics (1995) 1.96
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer (2006) 1.96
Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res (1996) 1.90
A new class of endogenous human retroviral genomes. Science (1985) 1.89
Genetic alterations in breast cancer. Genes Chromosomes Cancer (1995) 1.86
Nucleic acid homology of murine xenotropic type C viruses. J Virol (1975) 1.82
The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene (1997) 1.81
Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol (1995) 1.79
A refined molecular taxonomy of breast cancer. Oncogene (2011) 1.78
Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients. Proc Natl Acad Sci U S A (1985) 1.77
Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem (1999) 1.74
Detection and cloning of human DNA sequences related to the mouse mammary tumor virus genome. Proc Natl Acad Sci U S A (1982) 1.74
Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res (2001) 1.72
Somatic mutations and human breast cancer. A status report. Cancer (1992) 1.69
Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development. Cell Growth Differ (1995) 1.62
Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene (1995) 1.58
Novel class of mouse mammary tumor virus-related DNA sequences found in all species of Mus, including mice lacking the virus proviral genome. Proc Natl Acad Sci U S A (1982) 1.58
VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer (2000) 1.54
Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res (2000) 1.53
High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients. J Natl Cancer Inst (1986) 1.52
Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. Cancer Res (1986) 1.52
Endogenous primate and feline type C viruses. Cold Spring Harb Symp Quant Biol (1975) 1.51
Somatic allelic deletion of nm23 in human cancer. Cancer Res (1991) 1.50
A new class of genetically transmitted retravirus isolated from Mus cervicolor. Proc Natl Acad Sci U S A (1976) 1.46
A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17. J Virol (1987) 1.45
Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res (2001) 1.45
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. Br J Cancer (1994) 1.43
Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas. Cancer Res (1989) 1.41
Re: Prognostic importance of low c-erbB2 expression in breast tumors. J Natl Cancer Inst (1999) 1.41
Amplification of the int-2 gene in primary human breast tumors. Oncogene Res (1988) 1.40
Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br J Cancer (2000) 1.39
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J Med Genet (2008) 1.36
In vitro synthesis of adenovirus core proteins. J Virol (1974) 1.35
Cell-free synthesis of adenovirus coat proteins. J Biol Chem (1974) 1.34
Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res (1993) 1.33
Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene (2001) 1.29
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res (2000) 1.29
Reduced expression of INT-6/eIF3-p48 in human tumors. Int J Oncol (2001) 1.26
Ancestry of a human endogenous retrovirus family. J Virol (1989) 1.26
Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol (1990) 1.26
Male and female mouse DNAs can be discriminated using retroviral probes. Nature (1982) 1.24
(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci U S A (1994) 1.24
A new class of murine retroviruses: immunological and biochemical comparison of novel isolates from Mus cervicolor and Mus caroli. Virology (1977) 1.23
Identification of a novel NOTCH-4/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines. Oncogene (2000) 1.23
Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer. Cancer Res (1996) 1.22
Relationship between airway narrowing, patchy ventilation and lung mechanics in asthmatics. Eur Respir J (2007) 1.20
PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Oncogene (1998) 1.20
Evidence for the transforming activity of a truncated Int6 gene, in vitro. Oncogene (2001) 1.20
Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clin Cancer Res (1996) 1.20
Genetic relationship between the Mus cervicolor M432 retrovirus and the Mus Musculus intracisternal type A particle. J Virol (1981) 1.19
An endogenous mouse mammary tumor virus genome common in inbred mouse strains is located on chromosome 6. J Virol (1986) 1.19
Immunological relationship between the structural proteins of intracisternal A-particles of Mus musculus and the M432 retrovirus of Mus cervicolor. J Virol (1980) 1.18
Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. Oncogene (2009) 1.15
Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Proc Natl Acad Sci U S A (1990) 1.15
Mutations in the p53 gene in primary human breast cancers. Cancer Res (1991) 1.15
The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. Genomics (1997) 1.15
Long-term in vivo expression of genes introduced by retrovirus-mediated transfer into mammary epithelial cells. J Virol (1991) 1.15
Deletion mapping of chromosomal region 1p32-pter in primary breast cancer. Genes Chromosomes Cancer (1999) 1.15
Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene. Carcinogenesis (2001) 1.14
Two genetically transmitted BALB/c mouse mammary tumor virus genomes located on chromosomes 12 and 16. J Virol (1984) 1.13
Regulatory mutants of the tryptophan operon of Salmonella typhimurium. Genetics (1970) 1.13
Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer (1996) 1.12
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res (1998) 1.12
Analysis of adenovirus type 2 gene functions by cell-free translation of viral messenger RNA. Cold Spring Harb Symp Quant Biol (1975) 1.11
Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma. Oncogene Res (1988) 1.10
In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res (1988) 1.10